pharmaphorum

NOVEMBER 24, 2020

A merger involving two US digital health specialists and a blank cheque company has created a telemedicine player, called UpHealth, that is valued at more than $1.3 billion. The three-way deal combines UpHealth – which provides patient care management, telemedicine and digital pharmacy services and gives its name to the new group – with CloudBreak, which provides a video consultation platform for doctors and patients.

Packaging 138

Packaging Compounding Insurance Patient Care 138

Outsourcing Pharma

NOVEMBER 25, 2020

The new EU Pharmaceutical Strategy, adopted today by the European Commission, is designed to improve and accelerate patientsâ access to safe and affordable medicines and address unmet medical needs in the areas of antimicrobial resistance, cancer, and rare diseases.

97

97

Druggist

NOVEMBER 25, 2020

Citalopram is a popular antidepressant prescribed in the UK. It is also one of the most prescribed medicines in the UK. Although escitalopram is ‘related’ to citalopram, it significantly less prescribed. Today I will review differences between escitalopram and citalopram. Escitalopram vs citalopram, a summary of the post: Escitalopram vs citalopram: legal status.

Dosage 81

Dosage Hospitals 81

Pharma Times

NOVEMBER 27, 2020

It is hoped that the test will help detect cancer at a much earlier stage

63

63

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

NOVEMBER 27, 2020

A new EMA approval has expanded the use of Vertex Pharma’s exon-skipping cystic fibrosis therapy Symkevi to children as young as six if they have specific gene mutations. The regulator has given a green light to use of Symkevi (tezacaftor/ivacaftor) with Vertex’ Kalydeco (ivacaftor) in patients ages six years and older who have two copies of the F508del mutation in the CFTR gene, or one F508del copy and one of 14 other so-called “minimal function” mutations in CFTR.

Labelling 134

Labelling FDA 134

Outsourcing Pharma

NOVEMBER 23, 2020

The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidateâs potential in overcoming resistance of a cancer drug.

94

94

Pharma Times

NOVEMBER 27, 2020

The combination is the first available to treat the underlying cause of CF in this patient group.

55

55

pharmaphorum

NOVEMBER 27, 2020

Amanda Barrell explores how a perfect storm of changing economics, advances in technology, and the increasing volume of the patient voice is stoking change in the rare disease space. New models of drug development are fuelling life-changing advantages in the rare disease space, previously an economic no-go area for pharma and biotech companies. That was among the discussion points during Fighting Rare Diseases – The Science, Economics and the Patients , a webinar hosted by o2h Group.

132

132

Outsourcing Pharma

NOVEMBER 24, 2020

The two companies will collaborate on a Phase III clinical trial investigating a potential treatment for patients hospitalized with COVID-19.

Hospitals 90

Hospitals 90

Pharma Mirror

NOVEMBER 21, 2020

The Hague — To help pharmacists advise people on COVID-19 tests, the International Pharmaceutical Federation (FIP), has today issued a guidance document. The guidance has been produced by FIP’s SARS-CoV-2 Testing Working Group, which has evaluated the diagnostic testing methods and devices currently available. The document covers how different types of diagnostic test work and the interpretation of results.

Documentation 52

Documentation Immunization 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

NOVEMBER 27, 2020

Tepotinib could be the first treatment on the market for NSCLC in adults harbouring METex14 skipping alterations

51

51

pharmaphorum

NOVEMBER 23, 2020

Janssen’s Daniel de Schryver tells us why it’s time to give patients a permanent seat at the table and improve health outcomes through patient-pharma dialogue. I’m struck by just how much we thrive when we share a common purpose; when – as a society, a group or a family unit – we work together to achieve the same goal. It’s no different in healthcare.

Communication 128

Communication Documentation Vaccines 128

Outsourcing Pharma

NOVEMBER 23, 2020

The agency has given the go-ahead for use of baricitinib in conjunction with remdesivir for treating patients hospitalized with severe cases of the virus.

Hospitals 62

Hospitals FDA 62

Pharma Mirror

NOVEMBER 21, 2020

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its antiepileptic medications, with greater capabilities to expand across additional brands. The digital companions streamline support for patients to access financial assistance, patient diaries, and doctor discussion guides throughout their treatment journey.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

NOVEMBER 23, 2020

R&D spending in the sector last year represents an eight-year high

51

51

pharmaphorum

NOVEMBER 25, 2020

An artificial intelligence tool developed by GE Healthcare twinned with a mobile X-ray device can help the placement of endotracheal tubes (ETTs), a necessary step for COVID-19 patients who require ventilation. The new tool – part of GE’s Critical Care Suite 2.0 – helps bedside staff and radiologists assess patients before intubation and make sure ETTs are positioned correctly which should reduce complications.

Hospitals 122

Hospitals 122

Outsourcing Pharma

NOVEMBER 24, 2020

Intelligent Tissue Group has launched its Intelligent Clinical trials facility to help assess the effectiveness and safety of potential new treatments.

52

52

Med Ed 101

NOVEMBER 25, 2020

I was incredibly excited to pass the 1,000,000 podcast download milestone recently! I had no idea that there would be that many people that would be interested in learning about drugs. I have been blessed to receive many thank you’s and messages of appreciation for the podcast and the blog. These messages have been mini-rocket […]. The post An Unexpected Milestone – Thanksgiving Thank You appeared first on Med Ed 101.

40

40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

NOVEMBER 25, 2020

Shot will be evaluated in pregnant mothers and their newborn infants

Vaccines 50

Vaccines 50

pharmaphorum

NOVEMBER 25, 2020

AstraZeneca’s research chief has said that the more effective dosing regimen of its coronavirus vaccine was discovered by accident. According to Reuters , the AstraZeneca development team made a minor mistake that made them realise they could significantly boost the success rate of the vaccine, codenamed AZD1222. Results announced earlier this week showed that by giving a half dose, followed by a full dose a month later, the vaccine’s efficacy could be boosted from 62% to around 90%.

Vaccines 119

Vaccines Compounding 119

Outsourcing Pharma

NOVEMBER 25, 2020

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

52

52

Med Ed 101

NOVEMBER 22, 2020

Working with geriatric patients and providers in primary care, I definitely have to stay up to date with regards to diabetes therapy. There have been a couple of diabetes updates in 2020 that I wanted to make sure you were aware of. The SGLT2 inhibitors is a class of medication that is undergoing a lot […]. The post Two Diabetes Updates in 2020 appeared first on Med Ed 101.

40

40

Pharma Times

NOVEMBER 25, 2020

Deal will focus on developing small molecules against a number of diseases

49

49

pharmaphorum

NOVEMBER 25, 2020

Novartis’ pipeline is strong enough to overcome a $14 billion patent cliff as blockbuster drugs face generic competition in the coming years, analysts have said. Following a briefing with management, a team of analysts led by Peter Welford said that the big Swiss pharma will be propped up by its psoriasis and infectious diseases blockbuster Cosentyx for some time.

Hospitals 119

Hospitals 119

Outsourcing Pharma

NOVEMBER 25, 2020

The decentralized trial tech firmâs Verisense inertial measurement unit sensor has received the seal of approval from the Conformità EuropÃenne.

52

52

Druggist

NOVEMBER 27, 2020

This year, clascoterone (brand name: Winlevi) has been approved by The United States Food and Drug Administration (FDA) for treatment of acne in the US. In the UK, there are several options for the management of acne, including topical preparations and oral antibiotics. In this post, I will review clascoterone and compare it to other treatments available in the UK.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

Pharma Times

NOVEMBER 23, 2020

Effectiveness ranges from 62% to 90% depending on dosing regimen

Vaccines 49

Vaccines 49

pharmaphorum

NOVEMBER 24, 2020

Pharma sales is set to change forever. To keep afloat in the current climate, teams need to embrace flexibility and remember that traditional content won’t work in new contexts, say experts from Syneos Health. Selling in a socially-distanced world is about more than simply taking conversations online – it requires a wholesale change in how sales teams operate and the kinds of content they use.

Communication 119

Communication 119

Outsourcing Pharma

NOVEMBER 25, 2020

The company has received a $500,000 grant from the COVID-19 Therapeutics Accelerator to develop manufacturing processes for the antiviral drug remdesivir.

52

52

pharmaphorum

NOVEMBER 25, 2020

Trio Health’s Neil McGregor-Paterson asks whether the healthcare industry has paid enough attention to the patient voice during COVID-19 and looks at the many ways pharma can improve the patient experience across the sector going forward. Never has the health and care voluntary sector (HCVS) played such a critical role in supporting our nation´s health and wellbeing.

Hospitals 115

Hospitals Vaccines 115

pharmaphorum

NOVEMBER 24, 2020

The developer of Russia’s COVID-19 vaccine Sputnik V has pledged to make it available for less than $10 per dose – or $20 per two-dose course – on the same day as revealing new clinical data with the shot. Sputnik V ’s efficacy has remained high at 91.4% according to the latest analysis, which comes from almost 19,000 subjects who were assessed seven days after the second dose of the vaccine, administered 28 days after the first.

Vaccines 111

Vaccines Immunization 111

pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic. In the build-up to chancellor Rishi Sunak’s announcement in the House of Commons, the Association of the British Pharmaceutical Industry (ABPI) chief executive Richard Torbett warned that a no-deal Brexit could disrupt supplies of vaccines.

Vaccines 105

Vaccines Packaging 105

pharmaphorum

NOVEMBER 26, 2020

BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to market, but it’s still pushing forward on other fronts, including a partnership with InstaDeep to deploy artificial intelligence and machine learning across its business. The two companies have been working together in this area since 2019, but BioNTech has opted to double down on the alliance with a revised agreement focusing on new immunotherapies for cancer and infectious diseases.

Vaccines 105

Vaccines Immunization 105